Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

Go back to Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
(NASDAQ: BNGO) Delayed: 1.13 -0.05 (4.24%)
Previous Close $1.18    52 Week High $ 
Open $1.18    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.10    EPS $ 
Volume 251,891